Virios Therapeutics Inc
Change company Symbol lookup
Select an option...
VIRI Virios Therapeutics Inc
TCBS Texas Community Bancshares Inc
UPC Universe Pharmaceuticals Inc
MHH Mastech Digital Inc
GCTK GlucoTrack Inc
KODK Eastman Kodak Co
FYBR Frontier Communications Parent Inc
TPNEF Cub Energy Inc
ECC Eagle Point Credit Co LLC
CPHI China Pharma Holdings Inc
Go

Health Care : Biotechnology |
Company profile

Virios Therapeutics, Inc., formerly Virios Therapeutics, LLC., is a development-stage biotechnology company focused on advancing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM). Its lead development candidate is IMC-1, which is a fixed dose combination of famciclovir and celecoxib. IMC-1 represents a combination antiviral therapy designed to synergistically suppress Herpes Simplex Virus-1 (HSV-1) activation and replication. Its HSV-1 root cause of chronic illnesses such as FM, irritable bowel disease (IBS), chronic fatigue syndrome and functional somatic syndrome. The Company is developing its initial candidate, IMC-1, for people who are suffering from fibromyalgia.

Closing Price
$6.15
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
60,939
0

Thinking about trading options or stock in Coinbase Global, MicroStrategy, Alibaba, FedEx, or Tesla?

9:31 am ET June 24, 2022 (PR Newswire) Print

InvestorsObserver issues critical PriceWatch Alerts for COIN, MSTR, BABA, FDX, and TSLA.

https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report - Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.

-- COIN: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=COIN&prnumber=062420223

-- MSTR: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=MSTR&prnumber=062420223

-- BABA: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=BABA&prnumber=062420223

-- FDX: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=FDX&prnumber=062420223

-- TSLA: https://www.investorsobserver.com/lp/pr-options-lp-2/?symbol=TSLA&prnumber=062420223

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

https://c212.net/c/img/favicon.png?sn=CG99667&sd=2022-06-24

View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-coinbase-global-microstrategy-alibaba-fedex-or-tesla-301574890.html

SOURCE InvestorsObserver

https://rt.prnewswire.com/rt.gif?NewsItemId=CG99667&Transmission_Id=202206240931PR_NEWS_USPR_____CG99667&DateId=20220624

comtex tracking

COMTEX_409168746/1005/2022-06-24T09:31:09

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.